Consciousness Field Project: Intention Host Device-mediated Distant Intentionality
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03403764 |
|
Recruitment Status :
Completed
First Posted : January 19, 2018
Last Update Posted : January 2, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Wellness | Other: Wellness Intention | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 230 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Intervention Model Description: | Participants receive one of two alternative interventions during the initial phase of the study and receive the other intervention during the second phase of the study and are evaluated in parallel against a control group |
| Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
| Masking Description: | The investigator and participants involved in this clinical trial are prevented from having knowledge which intervention is assigned to individual participants. A second control group has no knowledge of the parallel conducted Consciousness Field Project. |
| Primary Purpose: | Supportive Care |
| Official Title: | Consciousness Field Project: Intention Host Device-mediated Distant Intentionality |
| Actual Study Start Date : | April 2016 |
| Actual Primary Completion Date : | November 1, 2019 |
| Actual Study Completion Date : | November 1, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Wellness Intention Transmission Groups
Aim of this part of the study is to examine whether intention broadcasted from an Intention Host Device (a device which stores and transmits an intention) will affect self-compassion, general wellness, and awakening. 300 trial participants will be randomly allocated to 1/3 in control and 2/3 in the experimental IHD group, respectively. Differences in outcomes between control and experimental groups are expected. To address potential bias, those who enter the study but drop out are compared to those who complete the study to gauge potential differences between the two groups, and will report on this potential bias in the published manuscript. |
Other: Wellness Intention
Other Name: Distant Intentionality |
|
No Intervention: Independent Control Group
Due to the "global, emergent entanglement" phenomenon, the investigators are curious if the investigators can test this idea within the context of the proposed study. The investigators added an additional but smaller control group which will complete the same three questionnaires for the first 6 months only and will be unaware of the larger study being conducted. These 50 subjects will be told they are completing the questionnaires in the context of a distinct, separate study and will be unaware of the Consciousness Field Project.
|
- Neff Self-Compassion Scale - Short Form [ Time Frame: 18 months ]The Neff Short Form consists of 12 questions cover Self-Kindness (2, 6), Self-Judgment (11, 12), Common Humanity (5, 10), Isolation (4, 8), Mindfulness (3, 7), Over-Identification (1, 9) and they are rated on a Likert scale from 1 (almost never) to 5 (almost always) with the total score derived by adding the means of each subscale together. The 6 subscales measure an individual's level of self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification. Sub scale scores are calculated as the mean of the sub scale items. The total self-compassion score reverses the negative sub scale items of self-judgment, isolation, over-identification (i.e. 1=5, 2=4, 3=3, 4=2, 1=5) to compute a total mean. Change from baseline for total and subscales are tracked. Higher scores indicate higher self-compassion
- NIH PROMIS Global Health Short Form [ Time Frame: 18 months ]PROMIS® Global Health Short Form (10 items). The 10 global health items include ratings of the five core PROMIS domains. It includes the most widely used self-rated health item (global01). PROMIS® includes a single item that provides a pure rating of physical health (global03) and another item for mental health (global04). Also included is an overall quality of life item (global02). The remaining items provide global ratings of physical function (global06), fatigue (global08), pain (global07), emotional distress (global10), and social health (global05 and global09). The 10 PROMIS® Global Health items each have 5 response choices, with the exception of the common 11-point pain intensity item ("How would you rate your pain on average" with 0=No pain and 10=Worst imaginable pain). Global 1-5, 9 range from 5 (Excellent) to 1 (Poor), with higher numbers meaning greater health. Certain items are restored (Global 7 such that 5=0 no pain, and 1=10 worst pain), Global8 (5=None, 1=Very Severe),
- The text analysis Linguistic Inquiry and Word Count (2007) [ Time Frame: 18 months ]Linguistic Inquiry and Word Count (2007) performs quantitative text analysis of freeform participant survey comments across a variety of content categories like emotion, affect, social, personal concern, biological processes, tone. The percentage of words in content categories will be tracked over time for increase in occurrence of positive categories and a decrease in occurrence in negative categories during broadcast relative to non-broadcast periods.
- Barrett Values Inventory [ Time Frame: 18 months ]Barrett Values Inventory offers additional, exploratory data related to the psychological and spiritual growth in the participants. This inventory requires participant's selection of 10 values from a set of 40 values and will be taken every three months. Based on the participant's selections, the inventory quantitatively and qualitatively maps their psychological and spiritual development across 7 dimensions (surviving, conforming, differentiating, individuating, self-actualizing, integrating, and serving). Based on a shift in the selection of values, the investigators will track the participants' progression through these 7 levels, with progression over time from Levels 1-3 (ego-based values) to Level 4 (individuation - facing change) and rising Levels 5-7 (spiritual values) being expressed as positive.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- volunteers over age 18 speaking English
Exclusion Criteria:
- Subjects who cannot read, anybody with a legally authorized representative (LAR), site/sponsor employees directly involved with the study and their family members, site/sponsor employees NOT directly involved with the study and their family members, statutory minors
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03403764
| United States, California | |
| Merraki Institute | |
| Palo Alto, California, United States, 94303 | |
| Study Director: | Paul Mills, Ph.D. | Professor of Family Medicine and Public Health, UC San Diego |
Publications:
| Responsible Party: | Dr. Gabriele Hilberg, PhD, MFT, Principal Investigator, Merraki Institute |
| ClinicalTrials.gov Identifier: | NCT03403764 |
| Other Study ID Numbers: |
001 |
| First Posted: | January 19, 2018 Key Record Dates |
| Last Update Posted: | January 2, 2020 |
| Last Verified: | December 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Intention Distant Healing Wellness Distant Intentionality Distant Healing Intention |

